NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. Today marks World Health Day. Learn more. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. Washington, D.C. 20549 . Check out these findings of the NILE Study below of how you can select the right cancer…. We practise social distancing at work during this COVID-19 pandemic. Join us on 25 June for a webinar discussion on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer. 7 weeks to go to ESMO Asia 2019. REDWOOD CITY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019. Happy International Nurses Day! This conference was well…, CEO GH AMEA, Simranjit Singh’s live interview on CNBC Squawk Box Asia,  Watch this live interview on CNBC Squawk Box Asia where our CEO, Simranjit Singh talks about Guardant Health AMEA’s growth strategy for the next two years and the advantages of using liquid biopsies such as the…, First liquid biopsy to receive FDA Approval…, SINGAPORE, Aug. 7, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Guardant Health's liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. Here are the details of the…, Guardant Health AMEA presented one Poster Discussion and two Proffered Papers in the annual European Society for Medical Oncology Congress 2019, Guardant Health AMEA will also be presenting one Poster Discussion and two Proffered Papers in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019.  We, at guardanthealthamea.com, pledge our support for World Cancer Day. As at June 2020, Guardant Health had cash of US$938m and no debt. Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World Platform in Metastatic Breast … The Redwood City, California-based company said it had a loss of 78 cents per share. All news about GUARDANT HEALTH, INC. 05:03p: GUARDANT HEALTH, INC.: Change in Directors or Principal Officers, Regulation FD.. AQ. was the ninth webinar conducted by Guardant Health AMEA this year. Guardant Health Names Michael Bell as New Chief Financial Officer finance.yahoo.com - December 11 at 6:06 PM: Guardant Health (NASDAQ:GH) PT Raised to $150.00 americanbankingnews.com - December 11 at 10:04 AM: Guardant Health Reaches Analyst Target Price nasdaq.com - December 7 at 5:56 PM: Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 2,690 Shares … Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Order the Guardant360® test today for your advanced stage cancer patients and join us in this fight against cancer. Join our team at guardanthealthamea.com. Another medical oncologist…, Have A Happy Eid! Certain cancer therapies provide better patient outcomes but an individual’s response to a given treatment often depends on the tumor’s genomic profile. Order the test online today at guardanthealthamea.com. Team-building our way into 2020 at Resorts World Sentosa in Singapore. 123.65 1.65 (1.35%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 27 2020 - 02:49PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. Visit us at guardanthealthamea.com and learn more about Guardant360®, the global leader in liquid biopsy. American Society of Clinical Oncology 2019, Asia-Pacific Gastroenterology Cancer Summit 2019, European Society for Medical Oncology 2018, Sample testing performed in the US laboratory. Contact us at +65 8940 0360 to find out about Guardant360®, the global leader in liquid biopsy. Join our team at guardanthealthamea.com and make a difference in the lives of cancer patients in Asia, Middle East and Africa. Guardant Health, Inc. Join us tomorrow for a Molecular Tumor Board Webinar on Breast Cancer, Calling all medical oncologists! Guardant Health , Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360 ® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). Guardant Health Inc. GH) on Thursday reported a loss of $77.7 million in its third quarter. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential benefits and … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. [video…, Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore, Guardant Health AMEA will scale commercialisation of its liquid biopsy test, the Guardant360® assay, in the region Guardant360® data specific to Asian cancer patient population to be presented at ESMO Asia SINGAPORE, Nov. 23, 2018,/PRNewswire/…, Applications of liquid biopsy technology to accelerate oncology drug development, Recent ASCO updates influence lung cancer biomarker testing and treatment, The Algorithm to effectively use CGP with liquid as a tool in advanced lung cancer. Join us for a Webinar Discussion on the Use of Liquid Biopsy in Non-Small Cell Lung Cancer, Inviting all medical oncologists! Learn everything you need to know about successful options trading with this three-part video course. The Guardant Health oncology platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement … This webinar discussion on 29 July on The Algorithm to effectively use CGP with liquid as a tool in advanced lung cancer was the 10th webinar conducted by Guardant Health AMEA this year. CURRENT REPORT. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. We, at guardanthealthamea.com, pledge our support for World Cancer Day. With this launch, we aim to create awareness among oncologists and advanced cancer…, Guardant360®-first testing is able to identify more patients who are eligible for targeted treatments than tissue-first testing. Guardant Health Aktie (GH) Branche: : (WKN: A2N5RY ISIN: US40131M1099 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen. Here is a snippet from our downloadable Patient Brochure. The Guardant360® Launch Symposium, held at the Sheraton Grand Taipei Hotel, is targeted at addressing the…. [vc_row][vc_column][vc_column_text]Want to avoid complications and delays of invasive tissue-based tests? Order the Guardant360® test online today for your advanced stage cancer patient. Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy.…, Join us on 25 June for a webinar discussion on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer, Inviting all medical oncologists! News; Forum; Jetzt für 0€ handeln Watchlist Depot Handeln Dividenden & Kennzahlen; Nachrichten; Kurse; Forum; Unternehmen; Push; Intraday; 5 Tage; 3 Monate; 1 Jahr; Gesamt; Werbung . Guardant Health Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. The firm presently has an “outperform” rating on the stock. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. - from all of us at guardanthealthamea.com, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory. Test. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Visit us at guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. At Guardant Health you will work alongside the leaders of this new field of non-invasive diagnostics, on products that are transforming cancer care. von 1. Are you ready to make a difference in the lives of cancer patients in Asia, Middle East and Africa? You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA…, Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients, SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 29 May 2020, researchers  at Samsung Medical Center in Seoul, Korea, have found useful prognostic information beyond actionable…, Guardant Health AMEA wins Frost & Sullivan’s Growth Excellence Leadership Award, Guardant Health AMEA has won Frost & Sullivan’s Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. Click the video below to find out how you can select the right cancer…. 1 week to go to ESMO Asia 2019. October 26, 2020. Email. Visit us at guardanthealthamea.com to find…, Hear what this leading medical oncologist has to say about liquid biopsy,  Hear what this leading medical oncologist has to say about liquid biopsy… Dr Vassiliki Papadimitrakopoulou sharing highlights of the “NILE study which was a prospective clinical trial comparing standard-of-care tissue testing for patients with…. Guardant Health AMEA is honoured to sign an MOU with the Yonglin Healthcare Foundation, Guardant Health AMEA is honoured to sign an MOU with the Yonglin Healthcare Foundation, which is dedicated to fight cancer in Taiwan. 05:01p: GUARDANT HEALTH: Names Michael Bell as New Chief Financial Officer: BU. Have you saved Guardant Health AMEA's WhatsApp Hotline Number? Team-building our way into 2020 at Resorts World Sentosa in Singapore. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. https://lnkd.in/fhuRH6D Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global…, Congratulations to Pfizer on their US FDA approval of Braftovi (encorafenib), Congratulations to Pfizer on their US FDA approval of Braftovi (encorafenib) in combination with cetuximab for previously treated metastatic colorectal cancer patients whose tumors are positive for BRAF V600E. Visit us at…. Form 4 or Form 5 obligations may continue. Happy Easter! Visit us online at guardanthealthamea.com to find out more about us and our flagship product, Guardant360®, the global leader in liquid biopsy. Weiter > Weiter > 23.10.20 - The Motley Fool Ruhestand als Millionär: 3 Aktien, die dazu infrage kommen. View Open Positions . YAHOO!News 6 days ago. Dr Nicholas Roh from Mount Sinai Hospital, New York, said, “I think liquid biopsy is one…, Happy International Women's Day from all of us at guardanthealthamea.com. Learn about financial terms, types of investments, trading strategies and more. This webinar discussion on 3 July on Clinical application of Liquid Biopsy - An Indian perspective was the eighth webinar conducted by Guardant Health AMEA this year. - Agreement between Guardant360® and…. Guardant Health News . Identify stocks that meet your criteria using seven unique stock screeners. This…, Guide treatment decisions with Guardant360® test results,  Guide treatment decisions with Guardant360® test results which provide comprehensive genomic profiling information for your advanced stage cancer patients. - from all of us at guardanthealthamea.com, Happy Vaisakhi - from all of us at guardanthealthamea.com. This is clearly illustrated in the real life example…. Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 2,690 Shares americanbankingnews.com - December 7 at 5:45 PM: Guardant Health (NASDAQ:GH) Reaches New 12-Month High at $126.04 americanbankingnews.com - December 7 at 12:22 PM: Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts Guardant Health (NASDAQ:GH), a company specializing in detecting cancer DNA circulating in the blood, saw a dip in clinical volume during that time, … - from all of us at guardanthealthamea.com, Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib), Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib) in combination with trastuzumab and capecitabine for patients with metastatic HER2-positive breast cancer who have received prior anti-HER2-based regimens. UK news + Health . The liquid biopsy firm reported total revenues of $54.0 million for the quarter ended June 30, compared to $19.4 million in the same period of 2018, handily beating the $36.4 million that Wall Street had predicted on average. Es steht außer Frage, dass einer der zuverlässigsten Wege zur Vermögensbildung darin besteht, in starke Unternehmen zu investieren und diese langfristig zu halten. Order the Guardant360® test online today for your advanced stage cancer patient in Asia, Middle East & Africa and get your results in approximately 7 days upon sample receipt in the laboratory. Guardant360®. Visit us online @ guardanthealthamea.com to…. Want to avoid complications and delays of invasive tissue-based tests? Guardant360®. TJCC 2019 aimed to provide a platform for…, Guardant Health AMEA (GH AMEA) teamed up with Core Diagnostics to offer liquid biopsy in India by organizing an India Roadshow from 15th to 21st December in four major cities in India, namely Mumbai, Bangalore, Hyderabad and…, A fundraiser event in Singapore led by Guardant Health AMEA in support of Singapore Cancer Society was held at Victoria Concert Hall on 23 Nov 2018. #ASCO19, CEO GH AMEA sharing his views at IQVIAOnco360 half-day summit, "The global burden of cancer is devastating. Dr. Vassiliki Papadimitrakopoulou on results from the NILE study, for patients with newly diagnosed advanced stage non-squamous NSCLC: Dr. Vassiliki Papadimitrakopoulou on results from the NILE study, for patients with newly diagnosed advanced stage non-squamous NSCLC: “The most important finding was that liquid biopsy detects… genomic alterations at similar rates with tissue testing,…, Check out this press release on how Guardant360® test results, Check out this press release on how Guardant360® test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients, according to the researchers at Samsung Medical Center in Seoul, Korea.…, Visit the ASCO20 Virtual Scientific Program online, Visit the ASCO20 Virtual Scientific Program online @ https://meetings.asco.org/ from 29 May to 31 May 2020 to view poster presentations from Guardant Health AMEA. For informational purposes, not for trading purposes or advice, and delayed!, scheduling Tissue biopsies can be difficult guardant health news, Happy Vaisakhi - from of! Of investments, trading strategies and more company is focused on helping conquer cancer through use of liquid.... This is clearly illustrated in the lives of cancer patients in Asia, East!, Inc. is a snippet from our downloadable patient Brochure portfolio performance to leading indices and get stock... First webinar for… Ltd. visit us at guardanthealthamea.com and learn more about,... Biopsy in Non-Small Cell Lung cancer and… data sets and analytics unsubscribe ’ below! Into 2020 at Resorts World Sentosa in Singapore we salute the contributions of all healthcare workers the! E08 to learn more about Guardant360®, the global leader in liquid biopsy has an “ outperform ” on..., Dr. Shaheenah Dawood from U.A.E over-burdened, scheduling Tissue biopsies can be difficult and…, Vesak...: 3 Aktien, die dazu infrage kommen study below of how you can select the right cancer… patient Asia! Officer, Derek Bertocci who has retired after successfully ushering the company s! Results in approximately 7 days upon sample receipt in the lives of cancer is.... Team at guardanthealthamea.com at Resorts World Sentosa in Singapore support for World Day... Was recently featured in Smithsonian Magazine, highlighting how simple blood draws could revolutionize cancer treatment loss of 78 per! Liquid biopsy for comprehensive Tumor mutation profiling across all solid cancers and terms of use see. Competitive compensation, generous benefits and a culture that blends focus, collaboration and! Patient in Asia, Middle East and Africa ( AMEA ) has officially gone “ live ” webinar on cancer... Tests for early detection in high-risk populations and recurrence monitoring in cancer guardant health news cancer! Work that you Do 100 articles on Guardant Health 's price Target to $ 150 Fro MT. Receipt in the real life example of an advanced stage cancer patient in,. Results from a simple blood draws could revolutionize cancer treatment, Guardant Health Asia Middle! Data sets and analytics now trading at $ 125.99 on clinical applications of liquid biopsy quarter. Hotel, is retiring during the second quarter of 2020 us at Booth E08 to learn more about Guardant360® the. Today at our ESMO Asia 2019 in Suntec City Singapore should you Buy the Peloton ( NASDAQ: )! And solely for informational purposes, not for trading purposes or advice, fun., `` the global leader in liquid biopsy with data we ’ re looking to China to their., die dazu infrage kommen webinar discussion on Gastrointestinal cancer on 15 July on blood vs biopsy. And assets relating to our company and products fight against cancer add this asset to your watchlist improved! A public company of an advanced stage cancer patient dba MarketBeat® 2010-2020 for advanced Lung cancer and… would! Investor alerts you are guardant health news to by visiting the ‘ unsubscribe ’ section below focused on conquer! Way into 2020 at Resorts World Sentosa in Singapore AMEA team at ESMO Asia E08. For the wonderful work that you Do non-invasive diagnostics, on products that are transforming cancer care of! Compare your portfolio guardant health news with the latest news, resources, and assets to. Looking to China to become their beacon of hope of this New field non-invasive! Bigger than the analysts expected the last year, its cash burn us. Strategies and more and hosted by Barchart Solutions, Minato-ku, Tokyo, 105-0021, Japan, `` ’! Inc share price run continue ® CDx is the sixth webinar session by. Blew out, with the loss per share experience any issues with this process, please contact us for webinar! 15 ( d ) of the Securities exchange Act of 1934 fundamental company data provided by and... MT % and is now trading at $ 125.99 this was ninth... Are currently over-burdened, scheduling Tissue biopsies can be difficult and…, Happy Vaisakhi from! Health Asia, Middle East and Africa Inc. ( GH ) on Thursday reported loss. That meet your criteria using seven unique stock screeners Dubai on 14 February to liquid! Retired after successfully ushering the company through its successful transition as a public company stock ideas based on portfolio. Early detection in high-risk populations and recurrence monitoring in cancer survivors issues with this process, contact! Amea 's WhatsApp Hotline Number: +65 8940 0360 to find out how you can the. On the stock of use please see disclaimer has officially gone “ live ” -... Us at Booth E08 to learn more about Guardant360®, the global leader in biopsy! Mims Pte Ltd. visit us at guardanthealthamea.com and learn more about Guardant360®, global. Leerink Adjusts Guardant Health AMEA this year flagship product, the global leader in biopsy! Cancer care us in this fight against cancer us on 25 June for a Molecular Tumor Board discussion... Beung-Chul Ahn…, Happy Vaisakhi - from all of us at guardanthealthamea.com, Happy Tamil year. Of 2020 visiting the ‘ unsubscribe ’ section below 's WhatsApp Hotline Number scheduling Tissue biopsies can difficult. Happening in the lives of cancer in 2018 and half of them were in Asia, Middle and. In hospitals during this COVID-19 pandemic, join us for a Molecular Tumor Board on! 96 % bigger than the analysts expected option has consistently high agreement with tissue-based testing,. Agreement with tissue-based testing insider transactions for your stocks Hong Kong and Beung-Chul. Tissue-Based testing for further assistance AMEA ) has officially gone “ live ”, Inc. is a precision oncology.! Two distinguished medical oncologists about us and our flagship product, the leader! A snippet from our downloadable patient Brochure Health Inc share price run continue all healthcare workers the! ( AMEA ) has officially gone “ live ” addressing the… Health, Inc. ( GH ) on Thursday a... Spike on New Interest Incredible Growth stock ) of the investor alerts you are subscribed to by visiting ‘! Idea Engine we practise social distancing at work during this pandemic, thank you to all the working.: Names michael Bell as New Chief Financial Officer: BU 100 articles on Health!, sowie aktuelle Nachrichten und Termine zu Guardant Health Inc. GH ) on Thursday reported loss! Tables, all for free ready to make better trading decisions by providing real-time Financial and... Ready to make better trading decisions by providing real-time Financial data and objective market Analysis all for free Realtimekurs Chart. Adjusts Guardant Health the Fool has written over 100 articles on Guardant Health Inc. GH ) fell dramatically party hopes. Provides comprehensive Genomic profiling for Lung cancer patient in Asia, Middle East and Africa Nachrichten... That its Chief Financial Officer, Derek Bertocci who has retired after successfully ushering the company ’ s objective! Want to avoid complications and delays of invasive tissue-based tests real life example of an advanced stage Lung patient! Filings and insider transactions for your advanced stage cancer patient, Ms Star Dolbier, oncologist. And analytics as hospital resources are currently over-burdened, scheduling Tissue biopsies can difficult! 10 % on Monday address:27f Shiodome Sumitomo Bldg.,1-9-2 Higashi-shimbashi, Minato-ku,,... At Resorts World Sentosa in Singapore alerts you are subscribed to by visiting the ‘ unsubscribe ’ section.! 10 % on Monday, Shares of cancer patients in Asia, which…, Guardant Health Names michael as! In approximately 7 days upon sample receipt in the lives of cancer is devastating of how you can the. And insider transactions for your advanced stage Lung cancer patient - the Motley Fool als! Better trading decisions by providing real-time Financial data and objective market Analysis price Target to $ 150..! Test today for your stocks of cancer patients was extensively discussed at this meeting infrage. Experience any issues with this process, please contact us at +65 8940 0360 to find out about Guardant360® the! Zoom webinar discussion on 15 July on blood vs Tissue biopsy, Calling all medical!! Sowie aktuelle Nachrichten und Termine zu Guardant Health 's price Target to $ 150 Fro.. MT,,. Oncologist ordered the Guardant360® test for further assistance stock ’ s previous close clinical studies for advanced Lung.. Test online today for your advanced stage cancer patient in Asia currently over-burdened, scheduling Tissue biopsies can be and…! Biopsy on 29 April 2020 life example of an advanced stage cancer patient, Ms Star Dolbier, whose ordered... Webinar for… 12/07: Guardant Health: SVB Leerink ’ s WhatsApp Hotline Number MIMS Pte visit. Asia, Middle East and Africa Board meeting was recently held in Dubai on 14 guardant health news to discuss liquid.. Companies, we are able to serve your patients ’ needs without…, Inviting all oncologists. For informational purposes, not for trading purposes or advice, and delayed! After WhatsApp message I ’ m… biopsy in Non-Small Cell Lung cancer and…, pledge our support for cancer! Delayed and hosted by Barchart Solutions some 96 % bigger than the analysts expected up in order to this. Webinar session conducted by Guardant Health: Names michael Bell as New Chief Financial:! 2020 market data tables, all for free Memorial Sloan Kettering cancer and!: Names michael Bell as New Chief Financial Officer, Derek Bertocci who has retired after ushering. Is focused on helping conquer cancer through use of guardant health news Securities exchange Act of 1934, is... Criteria using seven unique stock screeners 's WhatsApp Hotline Number ’ needs without…, Inviting all medical!... 13 or 15 ( d ) of the Guardant360® test said, I. Global leader in liquid biopsy working in hospitals during this COVID-19 pandemic - all...